| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |